Heads Up! Big News on Stem Cells & Covid This Weekend.
Gentlemen Start Your Research Engines! Be Fast and Be Early. We Could be Looking at a "Beam Me Up Scotty" Type Vector...
First Zebra (ZBRA) Then Checkpoint (CHKP), OMNIQ (OQMS) Strengthens Product Line-Up.
The Company You Keep..
First, tiny OMNIQ announces a partnership with Zebra (ZBRA) with $4 billion in revenues. And...
Investment Manager With $1 Billion in Assets Under Management, Buys 300 Hapbee (HAPB) Head...
Things that make you go mmmm.
Randy Eisenman is co-founder and managing partner of Satori Capital with more than...
And We Have Our First Bitcoin Double.
Galaxy Digital (GLXY.TO, BRPHF) $12.85, $9.75.
The story remains the same from exactly two months ago today. As...
Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.
Another Fatty Liver Idea. This Time a Play on Detecting Fatty Liver Non-Invasively. Heads Up. Nearing Resistance at $0.89.
Video: Okay, You Tested Positive for Corona, Now What?
https://youtu.be/vN30emwcNS4
Professor Roger Seheult,...
News, As Huge As It Gets, From Hepion Pharma (HEPA) $2.10.
Of course, approval news is the ultimate "as huge as it gets" news.
But at this stage...
A Medical Technology That Has The Highest Potential Over Any We Follow.
You Must Read This...
New Report on the People Behind EMulate Therapeutics.
200 Million...
Is The Market Overvalued? Barron’s Round Table January 2000.
Interesting viewpoints ahead of the market drifting from near 12,000 to 7,000. Equivalent to Dow dropping to near 20,000 today.
Remember President Trump Taking Dexamethasone? Hepion’s (HEPA) CRV431 demonstrated reduced lung inflammation and damage...
Hepion (HEPA) Announces FDA Clearance of IND Application for CRV431 for COVID-19
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
